Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
Vinay Sundaram, Rajiv Jalan, Tiffany Wu...
https://pubmed.ncbi.nlm.nih.gov/30576643/Actively Recruiting
Led by European Foundation for Study of Chronic Liver Failure · Updated on 2025-10-20
3000
Participants Needed
106
Research Sites
N/A
Total Duration
This research aims to compare 1-year survival rates of patients undergoing liver transplantation LT with different severities of liver failure, including those with acute-on-chronic liver failure ACLF grade 2 or 3 and those with decompensated cirrhosis without severe ACLF. It also assesses survival for patients with severe ACLF who are not listed for transplantation. The study explores factors influencing transplant decisions, outcomes on waiting lists, and post-transplant survival and quality of life. Participants are grouped into three categories those listed for LT with ACLF-2 or 3 at listing or who develop these conditions while waiting those listed with decompensated cirrhosis but without ACLF-2 or 3 and poor liver function MELD score above 20 and those with ACLF-2 or 3 assessed for listing but ultimately not listed. The study follows all groups for one year after transplantation or inclusion to observe outcomes. Participants will be monitored for survival, transplant listing decisions, waiting list outcomes, graft acceptance characteristics, and quality of life after LT. Data collection includes clinical evaluations and tracking of patient and graft survival for one year. The study is observational, collecting information to improve understanding of transplantation outcomes and organ allocation for patients with severe liver disease.
CONDITIONS
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
A
Anna Bosch
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
European Foundation for Study of Chronic Liver Failure
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year after inclusion or liver transplantation
Participants who are listed for liver transplantation or assessed for inclusion are observed for their health status and outcomes.
Participants have regular visits as part of their clinical follow-up during the study period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Vinay Sundaram, Rajiv Jalan, Tiffany Wu...
https://pubmed.ncbi.nlm.nih.gov/30576643/Thierry Gustot, Javier Fernandez, Elisabet Garcia...
https://pubmed.ncbi.nlm.nih.gov/25877702/Florent Artru, Alexandre Louvet, Isaac Ruiz...
https://pubmed.ncbi.nlm.nih.gov/28645736/European Foundation for Study of Chronic Liver Failure
Lead Sponsor